Best Pharmaceuticals for Children Act
Official title: “To amend the Federal Food, Drug, and Cosmetic Act to improve the safety and efficacy of pharmaceuticals for children.”
What this law changes
Not startedPlain-language account: Not started
Transparency Score
The Transparency Score is the share of this law’s dollars that goes to what the law says it is for. We have not read this law for this section yet.
What this law changes in taxes
We have not read this law for this section yet.
Press releases by members of Congress
From a secondary sourceThese are press releases from members' official websites that name this law. We save a copy of each one.
1 press release
-
In New Letter, Murray, Colleagues Demand NIH Director Restore Lifesaving Pediatric Research
“The PTN was authorized by Congress in the Best Pharmaceuticals for Children Act (BPCA) (P.L. 107-109), bipartisan legislation that authorized $25 million per year for trials of off-patent medicines and devices used in children. Since then, the PTN has developed into an NIH-funded consortium of over 100 clinical research sites across the United States dedicated to conducting studies on the”
Read from 539 of 539 members' sites, releases since January 3, 2025, through October 8, 2026.
Press releases by organizations
No saved press release from these organizations names this law.
Read from 510 of 510 organizations' sites, releases since January 3, 2025, through October 8, 2026.
How it passed
The Senate passed it without objection on December 12, 2001. No individual votes are recorded.
The House passed it by voice vote on December 18, 2001. A voice vote records no individual votes.
It became law on January 4, 2002.
How each member votes
Both chambers passed this law without a recorded vote, so no individual votes exist.
Where this comes from
A file marked "saved" is our own copy of the official file. The code beside it is its fingerprint, a short code that changes if the file's contents change. A file with no copy saved carries "Not published yet".